0001582313 2026-06-03 2026-06-03 0001582313 1 2026-06-03 2026-06-03 pure shares iso4217:USD 0001582313 false N/A N/A EX-FILING FEES S-8 S-8 Xenon Pharmaceuticals Inc. Equity Common Shares, no par value per share true 4400000 53.3 234520000 0.0001381 32387.21 234520000 32387.21 0 32387.21 <div class="item-list-element-wrapper" style="margin-left:2.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;margin-right:1.333%;min-width:2.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:2.602798752462246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">”), this Registration Statement shall also cover any additional common shares of the Registrant that become issuable under the 2026 Equity Incentive Plan (the “</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2026 Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">”) by reason of any share dividend, share split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding common shares.</span></div></div><div class="item-list-element-wrapper" style="margin-left:2.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.333%;min-width:2.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:2.602798752462246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $53.30 per share, the average of the high and low prices of the Registrant’s common shares as reported on The Nasdaq Global Market on June 2, 2026.</span></div></div>